Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 7;18(10):e1003799.
doi: 10.1371/journal.pmed.1003799. eCollection 2021 Oct.

The global burden of Plasmodium vivax malaria is obscure and insidious

Katherine E Battle  1 , J Kevin Baird  2   3
Affiliations

The global burden of Plasmodium vivax malaria is obscure and insidious

Katherine E Battle et al. PLoS Med. .

Abstract

J. Kevin Baird and colleagues, examine and discuss the estimated global burden of vivax malaria and it's biological, clinical, and public health complexity.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The global prevalence of patent Plasmodium vivax in 2017.
The mean predicted parasite rate of P. vivax is in people 1 to 99 years of age based on the analysis from Battle and colleagues is shown on a scale of low prevalence (blue) to high (red) with very low prevalence in light grey and nonendemic regions in white [3]. Global national shapefile obtained from the Malaria Atlas Project (MAP; https://malariaatlas.org/) and available for download through the malariaAtlas R package [109].
Fig 2
Fig 2
Relative burdens of risk (A) and estimated illness (B) due to P. vivax malaria among the WHO regions: WPRO is Western Pacific; SEARO is Southeast Asia; EMRO is Eastern Mediterranean; AFRO is Sub-Saharan Africa; and PAHO is the Americas.
Fig 3
Fig 3. National clinical burdens of P. vivax malaria.
The mean estimated clinical burdens of P. vivax malaria are shown on a scale of blue (very low burden) to red (high clinical burden) [3]. Global national shapefile obtained from the Malaria Atlas Project (MAP; https://malariaatlas.org/) and available for download through the malariaAtlas R package [109].
Fig 4
Fig 4
Global and region trends of P. vivax clinical incidence rate (A) and case counts (B) from 2000 to 2017 [3]. WPRO is Western Pacific; SEARO is Southeast Asia; EMRO is Eastern Mediterranean; AFRO is Sub-Saharan Africa; and PAHO is the Americas.
See this image and copyright information in PMC

References

    1. Institute for Health Metrics and Evaluation. Findings from the Global Burden of Disease Study 2017 [Internet]. Seattle, WA; 2018 [cited 2020 Oct 18]. Available from: www.healthdata.org.
    1. World Health Organization. World Malaria Report 2015. Geneva; 2015. Available from: https://www.who.int/malaria/publications/world-malaria-report-2015/repor....
    1. Battle KE, Lucas TCD, Nguyen M, Howes RE, Nandi AK, Twohig KA, et al.. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study. Lancet. 2019;394:332–43. doi: 10.1016/S0140-6736(19)31096-7 - DOI - PMC - PubMed
    1. Weiss DJ, Lucas TCD, Nguyen M, Nandi AK, Bisanzio D, Battle KE, et al.. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study. Lancet. 2019. Jul 27;394(10195):322–331. doi: 10.1016/S0140-6736(19)31097-9 - DOI - PMC - PubMed
    1. Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;(October):1–8. doi: 10.1038/nrmicro3364 - DOI - PubMed